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Abstract
Study Design: Mixed-methods cross-sectional study.
Objectives: Degenerative cervical myelopathy (DCM) is a common and disabling condition. While classically, assessment and
diagnosis has focused on neuromuscular symptoms, many other disabilities have been linked. The aim of this study was to explore
the consequences of DCM for those with lived experience, producing a long list to inform the development of a core outcome set
for DCM research.
Methods: A 2-stage process was used: a focus group session of people with DCM (PwCM) and their supporters (n¼ 8) discussed
the impact of DCM. This was used to develop a preliminary list of consequences, which were then placed into a survey of an online
community of DCM sufferers (n ¼ 224). Survey participants were asked to tick the consequences that they had experienced and
given the opportunity to submit additional. Additional consequences were reviewed by a group of healthcare professionals and
PwCM and included if not already represented. Demographic information including disease severity, age, and sex were captured
for sampling comparison.
Results: A total of 52 outcomes were identified from the focus group and nominally divided into 2 categories; symptoms (36
outcomes) and handicaps (18 outcomes), and further evaluated using a survey. All outcomes were recognized by at least 5% of
respondents. A further 16 outcomes were added following the survey.
Conclusions: A list of DCM consequences has been defined from the perspective of PwCM. This will now be evaluated as part of
AO Spine RECODE-DCM, an international multistakeholder collaboration to establish a core outcome set for research.
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Background
Degenerative cervical myelopathy (DCM) is an umbrella term
for injury of the cervical spinal cord due to degenerative
changes of the surrounding spinal structures.1 It is the most
common cause of spinal cord dysfunction worldwide, with
estimated prevalence as high as 2% in adults.2
As the conduit between brain and body, disease of the cer-
vical spinal cord can trigger a number of different symptoms.
Classically DCM assessment has focused on neuromuscular
function of the hands, arms, and legs, alongside bladder dys-
function.3-5 These domains, for example, are all measured by
the modified Japanese Orthopedic Association scale, the inter-
national standard on disease severity and reference for treat-
ment decision making.6 However, there are a number of reports
of broader and prevalent disability,7 including headaches,8
movement disorders,9 respiratory dysfunction,10 and hyperten-
sion.11 A screening tool developed in Japan identified chest
pain as predictive of DCM.12
It is noted that in our recent evaluation of artificial intelli-
gence, symptom checkers in the screening for DCM, we
synthesized a number of narrative reviews on the diagnosis
of myelopathy to generate a list of signs and symptoms. How-
ever, these articles did not universally overlap in their
description.7
Taken together, these findings question whether our defi-
nition of what symptoms are associated with DCM is cur-
rently too narrow. This is a timely question to consider on a
number of fronts.
First, time to diagnosis and treatment has been identified as
one of the few modifiable factors for improving treatment
response in DCM: analysis of the AO Spine datasets initially
identified <6 months as significant,13 and this has recently been
further refined to <4 months.14 Unfortunately, most wait on
average 2 to 5 years for treatment15,16 and many are never
diagnosed.1,2 Efforts to target earlier diagnosis will benefit
from a comprehensive understanding of potential signs and
symptoms, especially at an early stage.
Second, AO Spine RECODE-DCM (aospine.org/recode), an
international multistakeholder consensus process, has been
established to develop recommendations to improve research
efficiency in DCM.17,18 This includes the formation of a core
outcome set [COS], to standardize assessment and reporting in
research by defining the outcomes that should be reported as a
minimum. COS development starts with the development of a
“long list” of outcomes, which is put through a consensus pro-
cess, to decide which outcomes are most important or “Core.”
The formation of the “long list” of outcomes has been estab-
lished by a variety of means, including systematic review of
outcome reporting, domain mapping of outcome tools, and
stakeholder interviews or surveys.19 While professional prac-
tice is well represented through systematic review, this may not
represent the views of persons with DCM.5,20
The objective of this study therefore was to explore the
consequences of DCM with people living with DCM. This
would be used, alongside systematic reviews of medical
literature, to produce a “long list” of outcomes in DCM that
would be refined through a consensus process as part of AO
Spine RECODE-DCM.
Methods
A 2-stage process was undertaken (Figure 1): A focus group of
persons with DCM (PwCM)21 and their supporters participated
in a semistructured discussion on the impact of DCM, which
informed a survey of an online community of DCM sufferers.
The survey was granted ethical approval by the University of
Cambridge Human Biology Research Ethics Committee.
Semistructured Interviews
Attendees of a Patient and Public Involvement Day at Cam-
bridge University Hospital on September 21, 2017 hosted by
Myelopathy.org, a charity and support group for persons with
DCM, were invited to participate in a focus group. Conveni-
ence sampling was employed, with the event advertised to
registered members of Myelopathy.org. Participants were not
known to researchers beforehand. Participants were asked to
declare their age and gender. Attendees underwent a neurolo-
gical assessment by a neurosurgeon, including calculation of
their modified Japanese Orthopedic Association score (mJOA),
the international standard for disease severity.6
Previous qualitative work for outcome projects has identi-
fied that participants have difficulties with the term
“outcome.”19 Therefore prior to starting, alongside an outline
of the current research program and the goals of the session, a
group task was undertaken to list the potential effects of
taking a train journey.
The sessions were facilitated by 2 interviewers (BMD and
MRNK), both spinal surgeons and researchers experienced in
the field of DCM. The groups were initially interviewed sepa-
rately as “PwCM” and “Carers.” Interviewers aimed to cover
domains identified from the research literature (function, pain,
and quality of life),5 the subcategories of the international stan-
dard for DCM assessment, the mJOA (sensation, walking,
bladder function, hand strength),22 and “less known
symptoms.”7 Workshops were initiated through an open ques-
tion How does DCM affect you? This was to enable both the
establishment of a list of outcomes (as discussed in this article)
and to enable thematic analysis (presented in a separate article),
to provide context, significance, and intricacies of outcomes to
support the establishment of domains.
Potential outcomes were highlighted by the facilitators dur-
ing the workshops, and if the group was in agreement, noted on
a paper card, placed in the center of the group akin to a Word
Cloud. These were used to stimulate further discussion and to
allow carers to view PwCM responses and vice versa. Follow-
ing separate workshops, the groups were combined and further
opportunity given to add additional outcomes or perspective on
outcomes. This then led onto an outcome grouping exercise,
which is the subject of a separate article. In total, the 3 sessions
ran for 40 minutes. The sessions were audio-recorded and
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transcribed by 2 authors (DZK and SMF) with any discrepan-
cies settled by discussion and mutual agreement. Outcomes
identified on paper cards at the time were used to generate a
list of outcomes. These were reviewed by BMD, CM, and IS to
remove identical outcomes and group terms into common cate-
gories, in order to identify overlapping outcomes, which could
be combined. For any outcomes with ambiguous terminology,
investigators referred back to the audio transcripts for context,
and adapted the wording at their discretion. All changes were
made by mutual agreement. This revised outcome list was
externally validated using an online survey.
Online Survey
An internet survey was created using SurveyMonkey and is
reported according reported according to the Checklist for
Reporting Results of Internet E-Surveys (CHERRIES).23 Ethi-
cal approval was granted by the University of Cambridge. Par-
ticipants were initially provided with an overview of the study
and definition of DCM. By continuing into the survey, partici-
pants were confirming their diagnosis of DCM and providing
consent to participate. A series of initial questions was used to
provide sampling characteristics, including age, gender, history
of surgical treatment, length of symptoms and disease severity,
as measured using the self-reported mJOA score (p-mJOA).24
Respondents were then asked to tick which of the outcomes
they had experienced and given the option to submit additional
outcomes. Participants from the interview stage were contacted
and specifically asked not to participate in this survey.
The survey was advertised to an online community of DCM
sufferers, hosted by Myelopathy.org, an international charity
for DCM. Advertisement was specifically made through 2
email calls, blog features on Myelopathy.org, and shared posts
in Myelopathy Support, the peer-to-peer support community of
Myelopathy.org hosted on Facebook. This community has pre-
viously been used to support online survey initiatives in
DCM.25 The community is known to include a mix of pre- and
postsurgical treatment sufferers, with disease demographics in
keeping with the published literature. The only significant dif-
ference of note is the community has a higher proportion of
female sufferers, as is typical of e-health support groups.
There was no incentive offered for participation in the sur-
vey. Once completed, survey respondents could not edit their
results. IP addresses were tracked to prevent duplicate entries
and allow users to return to the survey where they left off.
Descriptive statistics were used to synthesize sampling data
and the demographics of those experiencing them. Outcomes
with a prevalence of greater than 5% were carried forward into
the final outcomes list. Outcomes with a prevalence of less than
5% or submitted as additional were reviewed by BMD, IS, and
CM to establish generalizability to DCM. For additional sub-
missions, this involved the independent processing of out-
comes as either out of scope, already represented or new.
Results were combined, and discrepancies settled by mutual




Eight individuals participated in the semistructured interviews,
including 5 PwCM (3 men and 2 women) and 3 supporters (all
women, 2 identifying as partners and 1 as a close friend). The
average age of PwCM was 53years. Four PwCM had under-
gone surgery for DCM, 3 within the past 2 years, and 1 over 2
years ago. One patient was awaiting surgery. All attendees
identified as White Caucasian. The median mJOA of 11
(+interquartile range [IQR] 2), indicating these PwCM had
moderate to severe DCM. The workshops generated 58, dis-
cretely recorded effects. PwCM provided more (54, 93%) than
carers (17, 29%). Carers identified 4 problems not reported by
PwCM; difficulty initiating urination, loss of coordination,
inability to make plans, and altered cognition (Supporting
Information 1, see Supplementary Material). The combining
of groups did not generate additional suggestions. These find-
ings were processed as outlined, and a shortlist of 52 outcomes
placed into an internet survey (Supporting Information 2, see
Supplementary Material).
Online Survey Phase
The list of outcomes generated from patient and carer inter-
views were processed by investigators, to generate a list of 52
•Focus group discussion 
audio recorded.
•Recordings transcribed & 
coded.
•N=8
•Simple content analysis to 
generate a list of outcomes 
•List of patient reported 
DCM outcomes validated in 
larger cohort of DCM 
sufferers using an online 
survey
•N=224
•Outcome list generated, to 
inform the development of the 
opening round of a Core 
Outcomes Initiative, RECODE-
DCM
Figure 1. Flow diagram proving an overview of the methodological process. Workshops with PwCM and carers was used to develop a list of
DCM effects. This were then processed by authors, including an individual suffering from DCM, and placed into an internet survey for DCM
sufferers, to capture wider perspective. The findings of this, including any additional suggestions was then processed and used to form a long list
of DCM outcomes. DCM, degenerative cervical myelopathy; PwCM, people with DCM.
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outcomes. These were nominally divided into 2 categories;
symptoms (36 outcomes) and handicaps (18 outcomes), to
break up the survey list.
The survey ran from January 2017 until November 2017.
The survey was accessed 294 times, including 8 duplicate
entries and 62 incomplete entries. Therefore 224 responses
underwent analysis. The respondents were on average 56.6
years old, lived with DCM for 8.2 years, and had a mJOA of
11.6. Respondents were more likely to be female (76%) and
undergone surgery (62%).
All 52 outcomes passed the predefined 5% threshold for
review (Figure 2). For internal consistency, erectile dysfunc-
tion was not reported by female respondents. It was instead
reported by 34% of male respondents. Otherwise, there was
no difference in gender, surgical history, mJOA, or timed lived
with DCM between those who did and did not report experi-
ence an outcome (Supporting Information 4, see Supplemen-
tary Material).
A total of 94 (42%) respondents submitted additional out-
comes (Supporting Information 3, see Supplementary Mate-
rial); 80 reporting additional symptoms and 52 additional
effects on life. Thirty-eight of these respondents submitted
additional information in both categories. In general, respon-
dents submitted multiple additional outcomes. The majority
were felt to already be represented. Noteworthy omissions
included headache (15 references), dizziness (10 references),
burning dysesthesia (10 references), stabbing/electrical shock
sensation (5 references), sexual dysfunction (6 references),
altered hearing (2 references), and altered vision (7 references)
(Table 1).
It should be noted that on initial review both hearing and
visual impairments were felt to not be directly related to DCM.
However, due to the number of submissions and on the basis of
inclusivity and given published literature was identified citing
similar observations in cervical spondylosis,26 these outcomes
were long-listed. An additional theme identified was the desire
to localize symptoms, particular sensory or pain symptoms
beyond upper and lower limb, including specific reference to
the shoulder and neck.
On this basis, the final long lists in Tables 2 and Table 3
were established. Outcomes that were included from the open-
ended survey questions are marked in red, in order to distin-
guish them from those that have been answered by the total
survey population.
Discussion
This is the first study to consider the effects of DCM from the
perspective of those living with the condition. The described
outcomes go far beyond our current “textbook” description of
the disease syndrome and the research assessments in common
0% 20% 40% 60% 80% 100%
Reduced grip strength
Reduced dexterity (less able to perform complex tasks with your…




Muscle spasms or twitches (in your legs)
Imbalance






Symptom variability day by day
Symptom variability hour by hour
Insomnia
Waking to go to the toilet
Difficulty breathing when performing physical acvity
Difficulty breathing when lying flat




















Unable to get up out of a chair
Unable to get out of bed
Muscle weakness
Reduced walking distance
Reduced acvity such that you are unable to have fun
Reduced acvity such that you are unable to work
Difficulty with travel
Difficulty with planning life
Inability to turn over in bed
Unable to get comfortable in bed
Difficules with social interacon
Financial difficules
Figure 2. Proportion of survey respondents expiring a listed symptom (orange bar chart) or effect on life (black bar chart). All outcomes were
experienced by at least 5% of surveyed individuals (vertical blue line).
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usage.5,7 It is also unique in using their own words to articulate
outcomes and providing an indication of symptom prevalence.
There are a number of noteworthy findings from this pro-
cess. First, the recognition of female sexual dysfunction and of
the different domains of sensation (eg, burning, paresthesia,
temperature). Second, the prevalence and impact of symptom
variability and sleep disturbance. Third, the experience of gas-
trointestinal and respiratory dysfunction. Fourth, the experi-
ence and prevalence of dyskinesias. Finally, the reporting of
symptoms beyond our conventional framework, including
headache, dizziness, visual, and auditory dysfunction.
Some of these experiences are not easily reconciled with our
conventional understanding of the pathophysiology of DCM. It
should be noted that the overall aim of this study was to pro-
duce a long list of patient-reported outcomes of DCM, without
predefined bias. This is therefore an inclusive list, to inform
future work. It should be interpreted in the context of its study
design and wider literature, as discussed below.
Limitations
Respondents belonged to a self-selecting group of individuals,
recruited from an online community, who were asked to con-
firm they had received a diagnosis of DCM by a medical pro-
fessional, after being presented with an explanation of the
disease for verification purposes. While interview participants
underwent clinical evaluation, no additional assessment was
carried out on survey participants. It is possible therefore that
some respondents did not have DCM and was also possible
participants had coexistent health conditions, with disability
misappropriated to DCM. While these are limitations of this
study design, the following mitigating factors should be noted.
First, long-listing of symptoms is typically restricted to inter-
views and the involvement of a large survey group (n¼ 224) is
an additional extension. Second, all interview outcomes were
widely represented in the survey, and no female selected the
gender-specific erectile dysfunction, indicating internal consis-
tency. Third, sampling demographics across outcomes was
consistent with the overall survey, and aside the noted female
predominance, those who had undergone surgery shared demo-
graphics with the leading prospective series from the literature.
Finally, the use of the internet has enabled an efficient
and broad reach of DCM, including a large sample of
pre-surgical DCM, poorly represented in the conventional
literature.18,25 Internet recruitment has been a mainstay of
core-outcome setting processes, with no additional validation.27
It should also be noted that a number of included outcomes
were taken from the open-ended survey question. While each
of these included multiple references (Table 3), they have not
undergone wider assessment. For clarity, these have been
marked as red in Tables 2 and 3.
As outlined, the principal aim of this study was to develop a
long list of outcomes from the perspective of those living with
DCM, in order to inform the AO Spine RECODE-DCM
COS.17 The findings of this study will be supplemented with
findings from literature reviews5,28 and refined using an online,
international DELPHI survey and finally a face to face consen-
sus meeting.
Findings in Context
Most of the reported outcomes can fit within our conventional
understanding of DCM, albeit they are rarely assessed as part of
clinical research5 or care.29 However, others less so.
This includes female sexual dysfunction, which unlike erec-
tile dysfunction, is not routinely evaluated.29 This likely relates
to it being an indirect consequence of DCM; one respondent
wrote Unable to orgasm—lack of sensation (Supporting Infor-
mation 4, see Supplementary Material). The importance of
sexual dysfunction to quality of life in traumatic spinal cord
injury was evidenced by Kim Anderson,30 but notably this was
largely among young male sufferers. The prevalence in DCM
needs to be explored among a larger population before firm
conclusions are drawn.
Likewise, sensation, which was frequently referenced by
PwCM, including a much broader breakdown of its perception












Time lived with DCM,
years, mean + SD
Headache 15 10.3 + 1.9 87 73 10.5 + 7.4
Dizziness 10 12.4 + 2.7 90 70 14.3 + 16.7
Burning 10 11.0 + 2.4 80 60 6.5 + 3.6
Stabbing/electrical shock (Lhermitte sign) 5 13.4 + 2.9 60 80 6.9 + 2.9
Sexual dysfunction 6 11.8 + 1.3 83 100 6.4 + 3.0
Hearing 2 8.5 + 0.5 100 100 10.3 + 5.8
Vision 7 11.0 + 4.0 86 57 10.8 + 12.1
Shoulder 6 11.3 + 2.4 83 50 14.7 + 8.7
Face 7 11.1 + 1.5 71 86 10.5 + 6.2
Abbreviations: mJOA, modified Japanese Orthopedic Association score; DCM, degenerative cervical myelopathy.
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and location than is routinely considered: the international
standard for disease severity, the mJOA, restricts this to none,
mild, moderate, or severe “numbness” in the hands only.22
While more sophisticated tools exist, none would assess all
of these domains or locations entirely.3 Clearly some pragma-
tism needs to be applied to clinical assessments and it is worth
noting that PwCM prioritize recovery of pain far beyond other
domains of sensation, indicating there are important differ-
ences to consider here.20
Our experience of traumatic spinal cord injury indicates the
potential for both respiratory, cardiovascular, gastrointestinal,
and involuntary movement outcomes.9,31 The striking feature
here is their purported prevalence in DCM, among a population
in whom this is not typically considered; 19% to 41% survey
respondents reported breathing difficulties and 38% to 66%
involuntary movement disorders. Recent studies have demon-
strated quantitative respiratory10,32 and cardiovascular dys-
function,33 which responds to DCM surgery. However,
typically these descriptions are of subclinical findings. The
experience reported by PwCM here is clearly conscious. It is
worth noting a screening questionnaire developed in a neuro-
surgical clinic in Japan for myelopathy found the presence of
chest tightness specific.12
Another prevalent and unexpected feature reported was
variability, with its logical impact on social planning and
enjoyment. This was reported by 66% of sufferers, with 42%
reporting it could change hour-by-hour. The emerging experi-
ence from assessment and management of mild myelopathy
does indicate that there can be an adaptation, with perhaps
Table 2. Final “Long List” of Patient-Reported Outcomes in
Degenerative Cervical Myelopathy (DCM), Relating to Direct
Symptoms.a











Cramps, spasms, or twitches - at arms or legs



























Difficulty breathing, when performing physical activity











a A number of symptoms could be experienced in different locations, and this is
referenced by the connecting brackets, including the perception or perceptions
and the suggestion locations. Some symptoms were taken from the open-
ended survey question and have therefore not been explored across the entire
survey population (in red).
Table 3. Long List of Patient-Reported Outcomes in Degenerative
Cervical Myelopathy (DCM), Relating to Life Effects, Referred to as
the Handicap.a




Unable to get out of chair
Unable to get out of bed
Unable to roll of in bed
Unable to get comfortable in bed
Reduced walking distance
Reduced activity that you are unable to have fun
Reduced activity such that you are unable to work
Difficulty with travel
Difficulty with life planning
Difficulties with social interaction
Financial difficulties
Difficulty parenting, and in family life
Reduced sex life
Difficulty thinking, concentrating, or remembering things
Fear of recurrent disease, or deterioration following trauma
aSome handicaps were taken from the open-ended survey question and have
therefore not been explored across the entire survey population (in red).
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slight improvement in disability without treatment in the short
term. The role of spinal cord hypoperfusion in the etiology of
DCM is also of interest here,34 with the mention of activity
dependent symptoms.
While referenced by numerous individuals, the “less
known” symptoms were not validated across the whole sur-
veyed population, instead submitted as additional suggestions
by respondents. In the literature, some of these “less known”
symptoms are labeled as “Barré-Liéou Syndrome.” The
famous French neurologist, who also described Guillain-
Barré syndrome, described a constellation of symptoms
secondary to altered sympathetic transmission as a result of
cervical spondylosis.35 The evidence base for this is low qual-
ity, and largely predates 1990. In the context of surgical treat-
ment, most recent research has stemmed from groups in
China, who describe symptom response with surgical treat-
ment.26,36 It should be noted components of this syndrome,
including cervicogenic headache37,38 and cervicogenic dizzi-
ness,36 have their own individualized research base, including
ICD (International Classification of Diseases) codes.
However, these associations remain controversial and it
should be noted that these series largely focus on cervical
spondylosis and not myelopathy. The link to myelopathy spe-
cifically may therefore be even more tentative.
We recently reported on an unusual case of sensory dys-
esthesia in DCM involving the body but also the face.39 Our
prevailing clinical view was that the facial symptoms repre-
sented a psychosomatic overlay but conceptualized that pro-
jections of the nucleus-tractus solitarius do project into the
cervical spinal cord and altered trigeminal nerve processing
was theoretically possible. Additionally, the emerging
evidence of structural cerebral re-organization in response
to myelopathy40,41 questions whether there is associated
altered central processing. Of note, Chen et al42 and Takenaka
et al43 using functional magnetic resonance imaging to inves-
tigate pre- and postsurgical connectivity changes in the brain
have both, independently, identified changes in the visual
cortex able to distinguish DCM from healthy controls, and
correlating with surgical outcome. While we therefore remain
skeptical, as popularized by Carl Sagan, An absence of
evidence is not evidence of absence. So, if the burden is truly
prevalent and significant among our population, regardless of
exact etiology, it warrants further consideration.
Conclusions
This study provides the first, comprehensive list of outcomes
associated with DCM from the perspective of people living
with the condition. Many reported outcomes are not currently
evaluated in clinical research or care. While many can be
reconciled within conventional understanding, many will be
controversial.
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